BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38461102)

  • 1. Fragility Fracture Network-Japan: The challenge of establishment of a national hip fracture database and successful achievement of nationwide health system change for hip fracture care in Japan.
    Yamamoto N; Sawaguchi T; Matsushita T; Katoh N; Arai H; Shirahama M; Endo N; Hagino H; Mori S; Teramoto T; Ookuro M; Hiraoka M; Takahashi HE
    Injury; 2024 Jun; 55(6):111452. PubMed ID: 38461102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.
    Tamaki J; Fujimori K; Ikehara S; Kamiya K; Nakatoh S; Okimoto N; Ogawa S; Ishii S; Iki M;
    Osteoporos Int; 2019 May; 30(5):975-983. PubMed ID: 30648192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
    Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
    Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global call to action to improve the care of people with fragility fractures.
    Dreinhöfer KE; Mitchell PJ; Bégué T; Cooper C; Costa ML; Falaschi P; Hertz K; Marsh D; Maggi S; Nana A; Palm H; Speerin R; Magaziner J; ; ; ; ; ;
    Injury; 2018 Aug; 49(8):1393-1397. PubMed ID: 29983172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct costs of osteoporosis-related hip fractures: protocol for a cross-sectional analysis of a national database.
    Maghbooli Z; Hossein-Nezhad A; Jafarpour M; Noursaadat S; Ramezani M; Hashemian R; Moattari S
    BMJ Open; 2017 Apr; 7(4):e014898. PubMed ID: 28400460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis in the European Union: a compendium of country-specific reports.
    Svedbom A; Hernlund E; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA;
    Arch Osteoporos; 2013; 8(1):137. PubMed ID: 24113838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.
    Mori T; Komiyama J; Fujii T; Sanuki M; Kume K; Kato G; Mori Y; Ueshima H; Matsui H; Tamiya N; Sugiyama T
    Arch Osteoporos; 2022 Apr; 17(1):61. PubMed ID: 35403938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan.
    Fujii T; Mori T; Komiyama J; Kuroda N; Tamiya N
    Arch Osteoporos; 2023 Jul; 18(1):103. PubMed ID: 37477723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
    Arch Osteoporos; 2021 Sep; 16(1):130. PubMed ID: 34510296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hip Fracture--Epidemiology, Management and Liaison Service. Prevention of the secondary hip fractures utilizing the regional post-referral treatment plan].
    Matsushita M
    Clin Calcium; 2015 Apr; 25(4):545-50. PubMed ID: 25814015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia.
    Sadat-Ali M; Al-Dakheel DA; Azam MQ; Al-Bluwi MT; Al-Farhan MF; AlAmer HA; Al-Meer Z; Al-Mohimeed A; Tabash IK; Karry MO; Rassasy YM; Baragaba MA; Amer AS; AlJawder A; Al-Bouri KM; ElTinay M; Badawi HA; Al-Othman AA; Tayara BK; Al-Faraidy MH; Amin AH
    Arch Osteoporos; 2015; 10():37. PubMed ID: 26494131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan.
    Mori T; Tamiya N; Jin X; Jeon B; Yoshie S; Iijima K; Ishizaki T
    Arch Osteoporos; 2018 Mar; 13(1):37. PubMed ID: 29603078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis.
    Taguchi Y; Inoue Y; Kido T; Arai N
    Arch Osteoporos; 2018 Apr; 13(1):45. PubMed ID: 29696390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study.
    Chen FP; Shyu YC; Fu TS; Sun CC; Chao AS; Tsai TL; Huang TS
    Osteoporos Int; 2017 Mar; 28(3):811-818. PubMed ID: 27832325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of osteoporosis liaison services on the expected lifetime osteoporosis-related medical expenses of patients with fragility fracture in a private hospital in Japan.
    Kobayashi S; Tanaka S; Yoshino Y; Tobita H; Kuwagaki K; Fujioka R; Totsuka H; Ichiba Y; Ishimine S; Sakamoto K; Ohama H; Kubo T
    Arch Osteoporos; 2022 Apr; 17(1):64. PubMed ID: 35416539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of a systematic approach to care and prevention of fragility fractures in New Zealand.
    Gill CE; Mitchell PJ; Clark J; Cornish J; Fergusson P; Gilchrist N; Hayman L; Hornblow S; Kim D; Mackenzie D; Milsom S; von Tunzelmann A; Binns E; Fergusson K; Fleming S; Hurring S; Lilley R; Miller C; Navarre P; Pettett A; Sankaran S; Seow MY; Sincock J; Ward N; Wright M; Close JCT; Harris IA; Armstrong E; Hallen J; Hikaka J; Kerse N; Vujnovich A; Ganda K; Seibel MJ; Jackson T; Kennedy P; Malpas K; Dann L; Shuker C; Dunne C; Wood P; Magaziner J; Marsh D; Tabu I; Cooper C; Halbout P; Javaid MK; Åkesson K; Mlotek AS; Brûlé-Champagne E; Harris R
    Arch Osteoporos; 2022 Aug; 17(1):108. PubMed ID: 35917039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SCHHS hip fracture clinical network experience-Improving care and outcomes through an interprofessional approach.
    Puckeridge G; Terblanche M; Massey D
    Int J Orthop Trauma Nurs; 2017 Aug; 26():24-29. PubMed ID: 28089404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hip fracture on hospital care costs: a population-based study.
    Leal J; Gray AM; Prieto-Alhambra D; Arden NK; Cooper C; Javaid MK; Judge A;
    Osteoporos Int; 2016 Feb; 27(2):549-58. PubMed ID: 26286626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporotic hip fracture costs in the elderly Turkish population.
    Hepgüler S; Cetin A; Değer C; Erkent U
    Acta Orthop Traumatol Turc; 2011; 45(5):316-25. PubMed ID: 22032996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Bone; 2022 Jul; 160():116396. PubMed ID: 35351673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.